Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: PAREXEL | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: PAREXEL

Revenues up 26% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL
 
4Q Revenues: $457.7 million (+26%)

4Q Earnings: $17.8 million (loss of $1.6 million in 4Q11)

FY Revenues: $1.6 billion (+14%)

FY Earnings: $63.2 million (+29%)

Comments: Clinical Research Services (CRS) was $292.1 million in the quarter, up 25%. PAREXEL Consulting & Medical Communications Services (PCMS) was $49.7 million (+41%). Perceptive Informatics (PI) service revenue was $50.8 million (+20%). New business wins were $601.9 million in the quarter, with a book-to-bill ratio of 1.53, generating backlog of approximately $4.4 billion. Loss in 4Q11 included restructuring charges of $4.3 million of facility-related costs, $1.5 million in severance costs, and $3.1 million in impairment charges related to exited facilities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters